Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study.

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Talisa, Victor B; Omer, Saad B; Mayr, Florian B

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Talisa, Victor B; Omer, Saad B; Mayr, Florian B.

Afiliación

Butt AA; VA Pittsburgh Healthcare System, Pennsylvania.
Yan P; Department of Medicine.
Shaikh OS; Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, and Doha, Qatar.
Talisa VB; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar.
Omer SB; VA Pittsburgh Healthcare System, Pennsylvania.
Mayr FB; VA Pittsburgh Healthcare System, Pennsylvania.

J Infect Dis ; 229(1): 147-154, 2024 Jan 12.

Article en En | MEDLINE | ID: mdl-37711076

Asunto(s)

COVID-19; Lactamas; Leucina; Nitrilos; Prolina; Humanos; Persona de Mediana Edad; Tratamiento Farmacológico de COVID-19; Prueba de COVID-19; Estudios de Cohortes; Ritonavir/uso terapéutico; Hospitalización; Puntaje de Propensión; Antivirales/uso terapéutico

Palabras clave

COVID-19; SARS-CoV-2; death; hospitalization; nirmatrelvir/ritonavir

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prolina / COVID-19 / Lactamas / Leucina / Nitrilos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google